4//SEC Filing
Minai-Azary Jennifer Lynn 4
Accession 0001842952-24-000019
CIK 0001842952other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 8:04 AM ET
Size
5.6 KB
Accession
0001842952-24-000019
Insider Transaction Report
Form 4
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-21+160,115→ 160,115 totalExercise: $1.07Exp: 2034-03-20→ Common Stock (160,115 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001844398
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 8:04 AM ET
- Size
- 5.6 KB